Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry

Molecular and Cellular Proteomics

Volumn 14, Issue 12, 2015, Pages 3105-3117

  Caron, Etienne ^a   Kowalewski, Daniel J ^b   Koh, Ching Chiek ^a   Sturm, Theo ^a   Schuster, Heiko ^b   Aebersold, Ruedi ^a,c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETER; MASS SPECTROMETRY; PEPTIDE ANALYSIS; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEOMICS; REVIEW; CELL MEMBRANE; CHEMISTRY; DEVICES; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEOMICS;

EID: 84948702563     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.O115.052431     Document Type: Review

References (159)

1. Caron, E., Vincent, K., Fortier, M.-H., Laverdure, J.-P., Bramoullé, A., Hardy, M.-P., Voisin, G., Roux, P. P., Lemieux, S., Thibault, P., and Perreault, C. (2011) The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol. Syst. Biol. 7, 533
2. Admon, A., and Bassani-Sternberg, M. (2011) The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing. Mol. Cell. Proteomics 10, O111.011833
3. Berlin, C., Kowalewski, D. J., Schuster, H., Mirza, N., Walz, S., Handel, M., Schmid-Horch, B., Salih, H. R., Kanz, L., Rammensee, H. G., Stevanoviæ, S., and Stickel, J. S. (2014) Mapping the HLA ligandome landscape of acute myeloidleukemia: A targeted approach toward peptide-based immunotherapy. Leukemia 29, 647-659
4. Kowalewski, D. J., Schuster, H., Backert, L., Berlin, C., Kahn, S., Kanz, L., Salih, H. R., Rammensee, H. G., Stevanovic, S., and Stickel, J. S. (2015) HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). Proc. Natl. Acad. Sci. U.S.A. 112, E166-175
5. Granados, D. P., Sriranganadane, D., Daouda, T., Zieger, A., Laumont, C. M., Caron-Lizotte, O., Boucher, G., Hardy, M. P., Gendron, P., Côté, C., Lemieux, S., Thibault, P., and Perreault, C. (2014) Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nat. Commun. 5, 3600
6. Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., and Mann, M. (2015) Mass spectrometry of human leukocyte antigen class I peppeptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteomics 14, 658-673
7. Hickman, H. D., and Yewdell, J. W. (2010) Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond. Proc. Natl. Acad. Sci. U.S.A. 107, 18747-18748
8. Dudek, N. L., Tan, C. T., Gorasia, D. G., Croft, N. P., Lling, P. T., and Purcell, A. W. (2012) Constitutive and inflammatory immunopeptidome of pancreatic β-cells. Diabetes 6, 3018-3025
9. Schellens, I. M. M., Hoof, I., Meiring, H. D., Spijkers, S. N., Poelen, M. C., van Gaans-van den Brink, J. A., van der Poel, K., Costa, A. I., van Els, C. A., van Baarle, D., and Kesmir, C. (2015) Comprehensive analysis of the naturally processed peptide repertoire: Differences between HLA-A and B in the immunopeptidome. PLoS ONE 10, e0136417
10. Caron, E., Charbonneau, R., Huppé, G., Brochu, S., and Perreault, C. (2005) The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int. Immunol. 17, 1583-1596
11. Giam, K., Ayala-Perez, R., Illing, P. T., Schittenhelm, R. B., Croft, N. P., Purcell, A. W., and Dudek, N. L. (2015) A comprehensive analysis of peptides presented by HLA-A1. Tissue Antigens 85, 492-496
12. Roche, P. A., and Furuta, K. (2015) The ins and outs of MHC class IImediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203-216
13. Cresswell, P., Ackerman, A. L., Giodini, A., Peaper, D. R., and Wearsch, P. A. (2005) Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207, 145-157
14. Rist, M. J., Theodossis, A., Croft, N. P., Neller, M. A., Welland, A., Chen, Z., Sullivan, L. C., Burrows, J. M., Miles, J. J., Brennan, R. M., Gras, S., Khanna, R., Brooks, A. G., McCluskey, J., Purcell, A. W., Rossjohn, J., and Burrows, S. R. (2013) HLA peptide length preferences control CD8 T cell responses. J. Immunol. 191, 561-571
15. Burrows, J. M., Bell, M. J., Brennan, R., Miles, J. J., Khanna, R., and Burrows, S. R. (2008) Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition. Mol. Immunol. 45, 1818-1824
16. Kløverpris, H. N., Stryhn, A., Harndahl, M., Payne, R., Towers, G. J., Chen, F., Riddell, L., Walker, B. D., Ndung'u, T., Leslie, A., Buus, S., and Goulder, P. (2013) HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B∗57 that is distinct from HLAB58:01. J. Virol. 87, 10889-10894
17. Bell, M. J., Burrows, J. M., Brennan, R., Miles, J. J., Tellam, J., McCluskey, J., Rossjohn, J., Khanna, R., and Burrows, S. R. (2009) The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length. Mol. Immunol. 46, 1911-1917
18. Shastri, N., Schwab, S., and Serwold, T. (2002) Producing nature's genechips: The generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20, 463-493
19. Kambayashi, T., and Laufer, T. M. (2014) Atypical MHC class II-expressing antigen-presenting cells: Can anything replace a dendritic cell? Nat. Rev. Immunol. 14, 719-730
20. Marsh, S., Parham, P., and Barber, L. D. (2000) The HLA factsBook. Academic Press, London. 416 pp.
21. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329, 512-518
22. Garrett, T. P., Saper, M. A., Bjorkman, P. J., Strominger, J. L., and Wiley, D. C. (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342, 692-696
23. Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H. G. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296
24. Lazoura, E., Lodding, J., Farrugia, W., Day, S., Ramsland, P. A., and Apostolopoulos, V. (2009) Non-canonical anchor motif peptides bound to MHC class I induce cellular responses. Mol. Immunol. 46, 1171-1178
25. Cole, D. K. (2015) The ultimate mix and match: Making sense of HLA alleles and peptide repertoires. Immunol. Cell Biol. 93, 515-516
26. Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., and Engelhard, V. H. (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261-1263
27. Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E., Lin, L. C., Tscharke, D. C., and Purcell, A. W. (2013) Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog. 9, e1003129
28. Thommen, D. S., Schuster, H., Keller, M., Kapoor, S., Weinzierl, A. O., Chennakesava, C. S., Wang, X., Rohrer, L., von Eckardstein, A., Stevanovic, S., and Biedermann, B. C. (2012) Two preferentially expressed proteins protect vascular endothelial cells from an attack by peptidespecific CTL. J. Immunol. 188, 5283-5292
29. Apps, R., Meng, Z., Del Prete, G. Q., Lifson, J. D., Zhou, M., and Carrington, M. (2015) Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J. Immunol. 194, 3594-3600
30. Scull, K. E., Dudek, N. L., Corbett, A. J., Ramarathinam, S. H., Gorasia, D. G., Williamson, N. A., and Purcell, A. W. (2012) Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A02:01 ligands. Mol. Immunol. 51, 136-142
31. Hickman, H. D., Luis, A. D., Buchli, R., Few, S. R., Sathiamurthy, M., VanGundy, R. S., Giberson, C. F., and Hildebrand, W. H. (2004) Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J. Immunol. 172, 2944-2952
32. Buchsbaum, S., Barnea, E., Dassau, L., Beer, I., Milner, E., and Admon, A. (2003) Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics 55, 172-176
33. Hawkins, O. E., Vangundy, R. S., Eckerd, A. M., Bardet, W., Buchli, R., Weidanz, J. A., and Hildebrand, W. H. (2008) Identification of breast cancer peptide epitopes presented by HLA-A∗0201. J. Proteome Res. 7, 1445-1457
34. Ben Dror, L., Barnea, E., Beer, I., Mann, M., and Admon, A. (2010) The HLA-B∗ 2705 peptidome. Arthritis Rheum. 62, 420-429
35. Marcilla, M., Alpízar, A., Lombardía, M., Ramos-Fernandez, A., Ramos, M., and Albar, J. P. (2014) Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue. Mol. Cell. Proteomics 13, 462-474
36. Schittenhelm, R. B., Lim Kam Sian, T. C. C., Wilmann, P. G., Dudek, N. L., and Purcell, A. W. (2014) Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLAB27 allotypes. Arthritis Rheum. 67, 702-713
37. Tan, C. T., Croft, N. P., Dudek, N. L., Williamson, N. A., and Purcell, A. W. (2011) Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11, 2336-2340
38. de Verteuil, D., Muratore-Schroeder, T. L., Granados, D. P., Fortier, M.-H., Hardy, M.-P., Bramoullé, A., Caron, E., Vincent, K., Mader, S., Lemieux, S., Thibault, P., and Perreault, C. (2010) Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol. Cell. Proteomics 9, 2034-2047
39. Fortier, M. H., Caron, E., Hardy, M. P., Voisin, G., Lemieux, S., Perreault, C., and Thibault, P. (2008) The MHC class I peptide repertoire is molded by the transcriptome. J. Exp. Med. 205, 595-610
40. Bozzacco, L., Yu, H., Zebroski, H. A., Dengjel, J., Deng, H., Mojsov, S., and Steinman, R. M. (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J. Proteome Res. 10, 5016-5030
41. Dutoit, V., Herold-Mende, C., Hilf, N., Schoor, O., Beckhove, P., Bucher, J., Dorsch, K., Flohr, S., Fritsche, J., Lewandrowski, P., Lohr, J., Rammensee, H.-G., Stevanovic, S., Trautwein, C., Vass, V., Walter, S., Walker, P. R., Weinschenk, T., Singh-Jasuja, H., and Dietrich, P.-Y. (2012) Exploiting the glioblastoma peptidome to discover novel tumourassociated antigens for immunotherapy. Brain 135, 1042-1054
42. Cresswell, P., Turner, M. J., and Strominger, J. L. (1973) Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments. Proc. Natl. Acad. Sci. U.S.A. 70, 1603-1607
43. Peterson, P. A., Rask, L., and Lindblom, J. B. (1974) Highly purified papain-solubilized HL-A antigens contain beta2-microglobulin. Proc. Natl. Acad. Sci. U.S.A. 71, 35-39
44. Nathenson, S. G., Uehara, H., Ewenstein, B. M., Kindt, T. J., and Coligan, J. E. (1981) Primary structural: Analysis of the transplantation antigens of the murine H-2 major histocompatibility complex. Annu. Rev. Biochem. 50, 1025-1052
45. Rötzschke, O., Falk, K., Wallny, H. J., Faath, S., and Rammensee, H. G. (1990) Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 249, 283-287
46. Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H. G. (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348, 252-254
47. Falk, K., Rötzschke, O., and Rammensee, H. G. (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348, 248-251
48. Storkus, W. J., Zeh, H. J., 3rd Salter, R. D., and Lotze, M. T. (1993) Identification of T-cell epitopes: Rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. Emphasis Tumor Immunol. 14, 94-103
49. Van Bleek, G. M., and Nathenson, S. G. (1990) Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 348, 213-216
50. Antwi, K., Hanavan, P. D., Myers, C. E., Ruiz, Y. W., Thompson, E. J., and Lake, D. F. (2009) Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines. Mol. Immunol. 46, 2931-2937
51. Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., and Mann, M. (2015) Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteomics 14, 658-673
52. Bassani-Sternberg, M., Barnea, E., Beer, I., Avivi, I., Katz, T., and Admon, A. (2010) Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc. Natl. Acad. Sci. U.S.A. 107, 18769-18776
53. Kowalewski, D. J., and Stevanović, S. (2013) Biochemical large-scale identification of MHC class I ligands. Methods Mol. Biol. 960, 145-157
54. Mommen, G. P., Frese, C. K., Meiring, H. D., van Gaans-van den Brink, J., de Jong, A. P., van Els, C. A., and Heck, A. J. (2014) Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD). Proc. Natl. Acad. Sci. U.S.A. 111, 4507-4512
55. Kasuga, K. (2013) Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry. Methods Mol. Biol. 1023, 203-218
56. Galati, G., Arcelloni, C., Paroni, R., Heltai, S., Rovere, P., Rugarli, C., and Manfredi, A. A. (1997) Quantitative cytometry of MHC class I digestion from living cells. Cytometry 27, 77-83
57. Hassan, C., Kester, M. G., Oudgenoeg, G., de Ru, A. H., Janssen, G. M., Drijfhout, J. W., Spaapen, R. M., Jiménez, C. R., Heemskerk, M. H., Falkenburg, J. H., and van Veelen, P. A. (2014) Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes. J. Proteomics 109, 240-244
58. Domon, B., and Aebersold, R. (2006) Mass spectrometry and protein analysis. Science 312, 212-217
59. Aebersold, R., and Mann, M. (2003) Mass spectrometry-based proteomics. Nature 422, 198-207
60. Leitner, A., and Aebersold, R. (2013) SnapShot: Mass spectrometry for protein and proteome analyses. Cell 154, 252-252.e1
61. Granados, D. P., Laumont, C. M., Thibault, P., and Perreault, C. (2015) The nature of self for T cells-A systems-level perspective. Curr. Opin. Immunol. 34, 1-8
62. Mester, G., Hoffmann, V., and Stevanović, S. (2011) Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell. Mol. Life Sci. 68, 1521-1532
63. Hillen, N., and Stevanovic, S. (2006) Contribution of mass spectrometrybased proteomics to immunology. Expert Rev. Proteomics 3, 653-664
64. Picotti, P., Bodenmiller, B., and Aebersold, R. (2013) Proteomics meets the scientific method. Nat. Methods 10, 24-27
65. Liu, Y., Hüttenhain, R., Collins, B., and Aebersold, R. (2013) Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev. Mol. Diagn. 13, 811-825
66. Sajic, T., Liu, Y., and Aebersold, R. (2015) Using data-independent, high resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications. Proteomics Clin. Appl. 9, 307-321
67. Michalski, A., Damoc, E., Hauschild, J. P., Lange, O., Wieghaus, A., Makarov, A., Nagaraj, N., Cox, J., Mann, M., and Horning, S. (2011) Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole orbitrap mass spectrometer. Mol. Cell. Proteomics 10, M111.011015
68. Andrews, G. L., Simons, B. L., Young, J. B., Hawkridge, A. M., and Muddiman, D. C. (2011) Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). Anal. Chem. 83, 5442-5446
69. Nesvizhskii, A. I. (2010) A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J. Proteomics 73, 2092-2123
70. Shteynberg, D., Nesvizhskii, A. I., Moritz, R. L., and Deutsch, E. W. (2013) Combining results of multiple search engines in proteomics. Mol. Cell. Proteomics 12, 2383-2393
71. Escobar, H., Reyes-Vargas, E., Jensen, P. E., Delgado, J. C., and Crockett, D. K. (2011) Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides. J. Proteome Res. 10, 2494-2507
72. Ternette, N., Block, P., Sánchez-Bernabéu,Á., Borthwick, N., Pappalardo, E., Abdul-Jawad, S., Ondondo, B., Charles, P. D., Dorrell, L., Kessler, B. M., and Hanke, T. (2015) Early kinetics of HLA class I-associated peptidome of MVA.HIVconsv-infected cells. J. Virol. 89, 5760-5771
73. Hahne, H., Pachl, F., Ruprecht, B., Maier, S. K., Klaeger, S., Helm, D., Médard, G. M. E., Wilm, M., Lemeer, S., and Kuster, B. (2013) DMSO enhances electrospray response, boosting sensitivity of proteomic experiments. Nat. Methods 10, 989-991
74. Frese, C. K., Altelaar, A. F., van den Toorn, H., Nolting, D., Griep-Raming, J., Heck, A. J., and Mohammed, S. (2012) Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry. Anal. Chem. 84, 9668-9673
75. Frese, C. K., Zhou, H., Taus, T., Altelaar, A. F., Mechtler, K., Heck, A. J., and Mohammed, S. (2013) Unambiguous phosphosite localization using electron-transfer/higher-energy collision dissociation (EThcD). J. Proteome Res. 12, 1520-1525
76. Käll, L., Canterbury, J. D., Weston, J., Noble, W. S., and MacCoss, M. J. (2007) Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat. Methods 4, 923-925
77. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
78. Michalski, A., Cox, J., and Mann, M. (2011) More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J. Proteome Res. 10, 1785-1793
79. Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M., Ham, A.-J., Bunk, D. M., Kilpatrick, L. E., Billheimer, D. D., Blackman, R. K., Cardasis, H. L., Carr, S. A., Clauser, K. R., Jaffe, J. D., Kowalski, K. A., Neubert, T. A., Regnier, F. E., Schilling, B., Tegeler, T. J., Wang, M., Wang, P., Whiteaker, J. R., Zimmerman, L. J., Fisher, S. J., Gibson, B. W., Kinsinger, C. R., Mesri, M., Rodriguez, H., Stein, S. E., Tempst, P., Paulovich, A. G., Liebler, D. C., and Spiegelman, C. (2010) Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 9, 761-776
80. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., and White, F. M. (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U.S.A. 104, 5860-5865
81. Liu, H., Sadygov, R. G., and Yates, 3rd, J. R. (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201
82. Caron, E., Espona, L., Kowalewski, D. J., Schuster, H., Ternette, N., Alpízar, A., Schittenhelm, R. B., Ramarathinam, S. H., Lindestam Arlehamn, C. S., Chiek Koh, C., Gillet, L. C., Rabsteyn, A., Navarro, P., Kim, S., Lam, H., Sturm, T., Marcilla, M., Sette, A., Campbell, D. S., Deutsch, E. W., Moritz, R. L., Purcell, A. W., Rammensee, H.-G., Stevanovic, S., and Aebersold, R. (2015) An open-source computational and data resource to analyze digital maps of immunopeptidomes. eLife 4, e07661
83. Marx, V. (2013) Targeted proteomics. Nat. Methods 10, 19-22
84. Picotti, P., and Aebersold, R. (2012) Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions. Nat. Methods 9, 555-566
85. Gallien, S., Bourmaud, A., Kim, S. Y., and Domon, B. (2014) Technical considerations for large-scale parallel reaction monitoring analysis. J. Proteomics 100, 147-159
86. Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., and Coon, J. J. (2012) Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11, 1475-1488
87. Hogan, K. T., Sutton, J. N., Chu, K. U., Busby, J. A., Shabanowitz, J., Hunt, D. F., and Slingluff, C. L., Jr. (2004) Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members. Cancer Immunol. Immunother. 54, 359-371
88. Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., Mulder, G. E., Toebes, M., Vesely, M. D., Lam, S. S., Korman, A. J., Allison, J. P., Freeman, G. J., Sharpe, A. H., Pearce, E. L., Schumacher, T. N., Aebersold, R., Rammensee, H.-G., Melief, C. J., Mardis, E. R., Gillanders, W. E., Artyomov, M. N., and Schreiber, R. D. (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577-581
89. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J. (2010) Skyline: An open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968
90. Reiter, L., Rinner, O., Picotti, P., Hüttenhain, R., Beck, M., Brusniak, M.-Y., Hengartner, M. O., and Aebersold, R. (2011) mProphet: Automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8, 430-435
91. Surinova, S., Hüttenhain, R., Chang, C. Y., Espona, L., Vitek, O., and Aebersold, R. (2013) Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nat. Protoc. 8, 1602-1619
92. Picotti, P., Rinner, O., Stallmach, R., Dautel, F., Farrah, T., Domon, B., Wenschuh, H., and Aebersold, R. (2010) High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat. Methods 7, 43-46
93. Picotti, P., Lam, H., Campbell, D., Deutsch, E. W., Mirzaei, H., Ranish, J., Domon, B., and Aebersold, R. (2008) A database of mass spectrometric assays for the yeast proteome. Nat. Methods 5, 913-914
94. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008) Selected reaction monitoring for quantitative proteomics: A tutorial. Mol. Syst. Biol. 4, 222
95. Lesur, A., and Domon, B. (2015) Advances in high-resolution accurate mass spectrometry application to targeted proteomics. Proteomics 15, 880-890
96. MacLean, B., Tomazela, D. M., Abbatiello, S. E., Zhang, S., Whiteaker, J. R., Paulovich, A. G., Carr, S. A., and Maccoss, M. J. (2010) Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal. Chem. 82, 10116-10124
97. Holstein Sherwood, C. A., Gafken, P. R., and Martin, D. B. (2011) Collision energy optimization of b-and y-ions for multiple reaction monitoring mass spectrometry. J. Proteome Res. 10, 231-240
98. Sherwood, C. A., Eastham, A., Lee, L. W., Risler, J., Mirzaei, H., Falkner, J. A., and Martin, D. B. (2009) Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets. J. Proteome Res. 8, 3746-3751
99. Kennedy, J. J., Abbatiello, S. E., Kim, K., Yan, P., Whiteaker, J. R., Lin, C., Kim, J. S., Zhang, Y., Wang, X., Ivey, R. G., Zhao, L., Min, H., Lee, Y., Yu, M. H., Yang, E. G., Lee, C., Wang, P., Rodriguez, H., Kim, Y., Carr, S. A., and Paulovich, A. G. (2014) Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Nat. Methods 11, 149-155
100. Gallien, S., Duriez, E., Demeure, K., and Domon, B. (2013) Selectivity of LC-MS/MS analysis: Implication for proteomics experiments. J. Proteomics 81, 148-158
101. Schiffmann, C., Hansen, R., Baumann, S., Kublik, A., Nielsen, P. H., Adrian, L., von Bergen, M., Jehmlich, N., and Seifert, J. (2014) Comparison of targeted peptide quantification assays for reductive dehalogenases by selective reaction monitoring (SRM) and precursor reaction monitoring (PRM). Anal. Bioanal. Chem. 406, 283-291
102. Ronsein, G. E., Pamir, N., von Haller, P. D., Kim, D. S., Oda, M. N., Jarvik, G. P., Vaisar, T., and Heinecke, J. W. (2015) Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable lin-earity, dynamic range and precision for targeted quantitative HDL proteomics. J. Proteomics 113, 388-399
103. Gillet, L. C., Navarro, P., Tate, S., Röst, H., Selevsek, N., Reiter, L., Bonner, R., and Aebersold, R. (2012) Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, O111.016717
104. Venable, J. D., Dong, M. Q., Wohlschlegel, J., Dillin, A., and Yates, J. R. (2004) Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 1, 39-45
105. Chapman, J. D., Goodlett, D. R., and Masselon, C. D. (2014) Multiplexed and data-independent tandem mass spectrometry for global proteome profiling. Mass Spectrom. Rev. 33, 452-470
106. Distler, U., Kuharev, J., and Tenzer, S. (2014) Biomedical applications of ion mobility-enhanced data-independent acquisition-based label-free quantitative proteomics. Expert Rev. Proteomics 11, 675-684
107. Law, K. P., and Lim, Y. P. (2013) Recent advances in mass spectrometry: Data independent analysis and hyper reaction monitoring. Expert Rev. Proteomics 10, 551-566
108. Röst, H. L., Rosenberger, G., Navarro, P., Gillet, L., Miladinović, S. M., Schubert, O. T., Wolski, W., Collins, B. C., Malmström, J., Malmström, L., and Aebersold, R. (2014) OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat. Biotechnol. 32, 219-223
109. Rosenberger, G., Koh, C. C., Guo, T., Röst, H. L., Kouvonen, P., Collins, B. C., Heusel, M., Liu, Y., Caron, E., Vichalkovski, A., Faini, M., Schubert, O. T., Faridi, P., Ebhardt, H. A., Matondo, M., Lam, H., Bader, S. L., Campbell, D. S., Deutsch, E. W., Moritz, R. L., Tate, S., and Aebersold, R. (2014) A repository of assays to quantify 10,000 human proteins by SWATH-MS. Sci. Data 1, 140031
110. Collins, B. C., Gillet, L. C., Rosenberger, G., Röst, H. L., Vichalkovski, A., Gstaiger, M., and Aebersold, R. (2013) Quantifying protein interaction dynamics by SWATH mass spectrometry: Application to the 14-3-3 system. Nat. Methods 10, 1246-1253
111. Schubert, O. T., Gillet, L. C., Collins, B. C., Navarro, P., Rosenberger, G., Wolski, W. E., Lam, H., Amodei, D., Mallick, P., MacLean, B., and Aebersold, R. (2015) Building high-quality assay libraries for targeted analysis of SWATH MS data. Nat. Protoc. 10, 426-441
112. Liu, Y., Chen, J., Sethi, A., Li, Q. K., Chen, L., Collins, B., Gillet, L.C., Wollscheid, B., Zhang, H., and Aebersold, R. (2014) Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol. Cell. Proteomics 13, 1453-1768
113. Liu, Y., Buil, A., Collins, B. C., Gillet, L. C., Blum, L. C., Cheng, L. Y., Vitek, O., Mouritsen, J., Lachance, G., Spector, T. D., Dermitzakis, E. T., and Aebersold, R. (2015) Quantitative variability of 342 plasma proteins in a human twin population. Mol. Syst. Biol. 11, 786-786
114. Guo, T., Kouvonen, P., Koh, C. C., Gillet, L. C., Wolski, W. E., Röst, H. L., Rosenberger, G., Collins, B. C., Blum, L. C., Gillessen, S., Joerger, M., Jochum, W., and Aebersold, R. (2015) Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat. Med. 21, 407-413
115. Selevsek, N., Chang, C. Y., Gillet, L. C., Navarro, P., Bernhardt, O. M., Reiter, L., Cheng, L.-Y., Vitek, O., and Aebersold, R. (2015) Reproducible and consistent quantification of the Saccharomyces cerevisiae proteome by SWATH-mass spectrometry. Mol. Cell. Proteomics 14, 739-749
116. Schubert, O. T., Ludwig, C., Kogadeeva, M., Zimmermann, M., Rosenberger, G., Gengenbacher, M., Gillet, L. C., Ben C Collins, Röst, H. L., Kaufmann, S. H., Sauer, U., and Aebersold, R. (2015) Absolute proteome composition and dynamics during dormancy and resuscitation of mycobacterium tuberculosis. Cell Host Microbe 18, 96-108
117. Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinović, S. M., Cheng, L.-Y., Messner, S., Ehrenberger, T., Zanotelli, V., Butscheid, Y., Escher, C., Vitek, O., Rinner, O., and Reiter, L. (2015) Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol. Cell. Proteomics 14, 1400-1410
118. Toprak, U. H., Gillet, L. C., Maiolica, A., Navarro, P., Leitner, A., and Aebersold, R. (2014) Conserved peptide fragmentation as a benchmarking tool for mass spectrometers and a discriminating feature for targeted proteomics. Mol. Cell. Proteomics 13, 2056-2071
119. Tsou, C.-C., Avtonomov, D., Larsen, B., Tucholska, M., Choi, H., Gingras, A.-C., and Nesvizhskii, A. I. (2015) DIA-umpire: Comprehensive computational framework for data-independent acquisition proteomics. Nat. Methods 12, 258-264
120. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A., and Stevanović, S. (1999) SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219
121. Karosiene, E., Lundegaard, C., Lund, O., and Nielsen, M. (2012) NetMHCcons: A consensus method for the major histocompatibility complex class I predictions. Immunogenetics 64, 177-186
122. Peters, B., Bui, H.-H., Frankild, S., Nielsen, M., Lundegaard, C., Kostem, E., Basch, D., Lamberth, K., Harndahl, M., Fleri, W., Wilson, S. S., Sidney, J., Lund, O., Buus, S., and Sette, A. (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comp. Biol. 2, e65
123. Cobbold, M., De La Peña, H., Norris, A., Polefrone, J. M., Qian, J., English, A. M., Cummings, K. L., Penny, S., Turner, J. E., Cottine, J., Abelin, J. G., Malaker, S. A., Zarling, A. L., Huang, H. W., Goodyear, O., Freeman, S. D., Shabanowitz, J., Pratt, G., Craddock, C., Williams, M. E., Hunt, D. F., and Engelhard, V. H. (2013) MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci. Transl. Med. 5, 203ra125
124. Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., Hilf, N., Schoor, O., Fritsche, J., Mahr, A., Maurer, D., Vass, V., Trautwein, C., Lewandrowski, P., Flohr, C., Pohla, H., Stanczak, J. J., Bronte, V., Mandruzzato, S., Biedermann, T., Pawelec, G., Derhovanessian, E., Yamagishi, H., Miki, T., Hongo, F., Takaha, N., Hirakawa, K., Tanaka, H., Stevanovic, S., Frisch, J., Mayer-Mokler, A., Kirner, A., Rammensee, H.-G., Reinhardt, C., and Singh-Jasuja, H. (2012) Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. 18, 1254-1261
125. Moutaftsi, M., Peters, B., Pasquetto, V., Tscharke, D. C., Sidney, J., Bui, H.-H., Grey, H., and Sette, A. (2006) A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24, 817-819
126. Caron, E., Vincent, K., Fortier, M. H., Laverdure, J.-P., Bramoullé, A., Hardy, M. P., Voisin, G., Roux, P. P., Lemieux, S., Thibault, P., and Perreault, C. (2011) The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol. Syst. Biol. 7, 533
127. Weinzierl, A. O., Lemmel, C., Schoor, O., Müller, M., Krüger, T., Wernet, D., Hennenlotter, J., Stenzl, A., Klingel, K., Rammensee, H. G., and Stevanovic, S. (2007) Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol. Cell. Proteomics 6, 102-113
128. Granados, D. P., Yahyaoui, W., Laumont, C. M., Daouda, T., Muratore-Schroeder, T. L., Côté, C., Laverdure, J.-P., Lemieux, S., Thibault, P., and Perreault, C. (2012) MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood 119, e181-91
129. Milner, E., Barnea, E., Beer, I., and Admon, A. (2006) The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol. Cell. Proteomics 5, 357-365
130. Milner, E., Gutter-Kapon, L., Bassani-Strenberg, M., Barnea, E., Beer, I., and Admon, A. (2013) The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome. Mol. Cell. Proteomics 12, 1853-1864
131. Bourdetsky, D., Schmelzer, C. E., and Admon, A. (2014) The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc. Natl. Acad. Sci. U.S.A. 111, E1591-E1599
132. Johnstone, C., Lorente, E., Barriga, A., Barnea, E., Infantes, S., Lemonnier, F. A., David, C. S., Admon, A., and López, D. (2015) The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus. Mol. Cell. Proteomics 14, 893-904
133. Hassan, C., Kester, M. G., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A., Heemskerk, M. H., Falkenburg, J. H., and van Veelen, P. A. (2013) The human leukocyte antigen-presented ligandome of B lymphocytes. Mol. Cell. Proteomics 12, 1829-1843
134. Trujillo, J. A., Croft, N. P., Dudek, N. L., Channappanavar, R., Theodossis, A., Webb, A. I., Dunstone, M. A., Illing, P. T., Butler, N. S., Fett, C., Tscharke, D. C., Rossjohn, J., Perlman, S., and Purcell, A. W. (2014) The cellular redox environment alters antigen presentation. J. Biol. Chem. 289, 27979-27991
135. Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., Wansley, E. K., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., van Veelen, P., and Neefjes, J. J. (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 203, 1259-1271
136. Adamopoulou, E., Tenzer, S., Hillen, N., Klug, P., Rota, I. A., Tietz, S., Gebhardt, M., Stevanovic, S., Schild, H., Tolosa, E., Melms, A., and Stoeckle, C. (2013) Exploring the MHC-peptide matrix of central tolerance in the human thymus. Nat. Commun. 4, 2039
137. Couzin-Frankel, J. (2013) Breakthrough of the year 2013. Cancer immunotherapy. Science 342, 1432-1433
138. Sharma, P., and Allison, J. P. (2015) The future of immune checkpoint therapy. Science 348, 56-61
139. Alfaro, J. A., Sinha, A., Kislinger, T., and Boutros, P. C. (2014) Oncoproteogenomics: Cancer proteomics joins forces with genomics. Nat. Methods 11, 1107-1113
140. Nesvizhskii, A. I. (2014) Proteogenomics: Concepts, applications and computational strategies. Nat. Methods 11, 1114-1125
141. Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., Modrusan, Z., Mellman, I., Lill, J. R., and Delamarre, L. (2014) Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572-576
142. Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W. R., Hildebrand, W. H., Mardis, E. R., and Linette, G. P. (2015) A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 348, 803-808
143. Hombrink, P., Hassan, C., Kester, M. G., de Ru, A. H., van Bergen, C. A., Nijveen, H., Drijfhout, J. W., Falkenburg, J. H., Heemskerk, M. H., and van Veelen, P. A. (2013) Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach. J. Immunol. 190, 3869-3877
144. Hombrink, P., Hassan, C., Kester, M. G., Jahn, L., Pont, M. J., de Ru, A. H., van Bergen, C. A., Griffioen, M., Falkenburg, J. H., van Veelen, P. A., and Heemskerk, M. H. (2015) Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte derived HLA-ligandome using a reverse immunology approach. Clin. Cancer Res. 21, 2177-2186
145. Schumacher, T. N., Kesmir, C., and van Buuren, M. M. (2015) Biomarkers in cancer immunotherapy. Cancer Cell 27, 12-14
146. Schumacher, T. N., and Schreiber, R. D. (2015) Neoantigens in cancer immunotherapy. Science 348, 69-74
147. Gilchuk, P., Spencer, C. T., Conant, S. B., Hill, T., Gray, J. J., Niu, X., Zheng, M., Erickson, J. J., Boyd, K. L., McAfee, K. J., Oseroff, C., Hadrup, S. R., Bennink, J. R., Hildebrand, W., Edwards, K. M., Crowe, J. E., Jr., Williams, J. V., Buus, S., Sette, A., Schumacher, T. N., Link, A. J., and Joyce, S. (2013) Discovering naturally processed antigenic determinants that confer protective T cell immunity. J. Clin. Invest. 123, 1976-1987
148. Ovsyannikova, I. G., Johnson, K. L., 3rd, Bergen, H. R., and Poland, G. A. (2007) Mass spectrometry and peptide-based vaccine development. Clin. Pharmacol. Ther. 82, 644-652
149. Yaciuk, J. C., Skaley, M., Bardet, W., Schafer, F., Mojsilovic, D., Cate, S., Stewart, C. J., McMurtrey, C., Jackson, K. W., Buchli, R., Olvera, A., Cedeño, S., Plana, M., Mothe, B., Brander, C., West, J. T., and Hildebrand, W. H. (2014) Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. J. Virol. 88, 12992-13004
150. Wölk, B., Trautwein, C., Büchele, B., Kersting, N., Blum, H. E., Rammensee, H. G., Cerny, A., Stevanovic, S., Moradpour, D., and Brass, V. (2012) Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. PLoS ONE 7, e29286
151. Riemer, A. B., Keskin, D. B., Zhang, G., Handley, M., Anderson, K. S., Brusic, V., Reinhold, B., and Reinherz, E. L. (2010) A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2 epithelial cancers. J. Biol. Chem. 285, 29608-29622
152. Kumari, S., Wälchli, S., Fallang, L.-E., Yang, W., Lund-Johansen, F., Schumacher, T. N., and Olweus, J. (2014) Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes. Proc. Natl. Acad. Sci. U.S.A. 111, 403-408
153. Salimi, N., Fleri, W., Peters, B., and Sette, A. (2012) The immune epitope database: A historical retrospective of the first decade. Immunology 137, 117-123
154. Kelchtermans, P., Bittremieux, W., De Grave, K., Degroeve, S., Ramon, J., Laukens, K., Valkenborg, D., Barsnes, H., and Martens, L. (2014) Machine learning applications in proteomics research: How the past can boost the future. Proteomics 14, 353-366
155. Lynch, C. (2008) Big Data: How do your data grow? Nature 455, 28-29
156. Stein, L. D., Knoppers, B. M., Campbell, P., Getz, G., and Korbel, J. O. (2015) Data analysis: Create a cloud commons. Nature 523, 149-151
157. Schultze, J. L. (2015) Teaching "Big Data" analysis to young immunologists. Nat. Immunol. 16, 902-905
158. Hughes, C. S., Foehr, S., Garfield, D. A., Furlong, E. E., Steinmetz, L. M., and Krijgsveld, J. (2014) Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 757
159. Kanshin, E., and Thibault, P. (2014) Efficient sample processing for proteomics applications-Are we there yet? Mol. Syst. Biol. 10, 758